Cargando…
Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation
BACKGROUND: Myocardial fibrosis is an important contributor for development of diastolic dysfunction. We investigated the impact of sirolimus as primary immunosuppression on diastolic dysfunction and fibrosis progression among heart transplantation recipients. METHODS AND RESULTS: In 100 heart trans...
Autores principales: | Alnsasra, Hilmi, Asleh, Rabea, Oh, Jae K., Maleszewski, Joseph J., Lerman, Amir, Toya, Takumi, Chandrasekaran, Krishnaswamy, Bois, Melanie C., Kushwaha, Sudhir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955460/ https://www.ncbi.nlm.nih.gov/pubmed/33325244 http://dx.doi.org/10.1161/JAHA.120.018186 |
Ejemplares similares
-
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022) -
Outcomes after heart transplantation in patients with cardiac sarcoidosis
por: Asleh, Rabea, et al.
Publicado: (2022) -
Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation
por: Alnsasra, Hilmi, et al.
Publicado: (2019) -
Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
por: Asleh, Rabea, et al.
Publicado: (2022) -
Peripheral microvascular dysfunction is associated with plaque progression and adverse long‐term outcomes in heart transplant patients
por: Ozcan, Ilke, et al.
Publicado: (2021)